Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
6.38
+0.22 (3.57%)
At close: Jan 29, 2026, 4:00 PM EST
6.36
-0.02 (-0.31%)
After-hours: Jan 29, 2026, 7:08 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $1.13 billion as of January 29, 2026. Its market cap has increased by 322.95% in one year.
Market Cap
1.13B
Enterprise Value
924.73M
1-Year Change
322.95%
Ranking
Category
Stock Price
$6.38
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $1.13B, an increase of 160.66%. That is a compound annual growth rate of 21.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 1.10B | 14.71% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.19B |
| Iovance Biotherapeutics | 1.18B |
| ORIC Pharmaceuticals | 1.18B |
| MoonLake Immunotherapeutics | 1.16B |
| Septerna | 1.14B |
| Aktis Oncology | 1.11B |
| Phathom Pharmaceuticals | 1.11B |
| BridgeBio Oncology Therapeutics | 1.09B |